Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Topical viscous budesonide suspension for treatment of eosinophilic esophagitis.
Aceves SS, Dohil R, Newbury RO, Bastian JF. Aceves SS, et al. Among authors: dohil r. J Allergy Clin Immunol. 2005 Sep;116(3):705-6. doi: 10.1016/j.jaci.2005.05.011. J Allergy Clin Immunol. 2005. PMID: 16159647 No abstract available.
Esophageal remodeling in pediatric eosinophilic esophagitis.
Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH. Aceves SS, et al. Among authors: dohil r. J Allergy Clin Immunol. 2007 Jan;119(1):206-12. doi: 10.1016/j.jaci.2006.10.016. J Allergy Clin Immunol. 2007. PMID: 17208603
Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder.
Aceves SS, Newbury RO, Dohil R, Schwimmer J, Bastian JF. Aceves SS, et al. Among authors: dohil r. J Clin Gastroenterol. 2007 Mar;41(3):252-6. doi: 10.1097/01.mcg.0000212639.52359.f1. J Clin Gastroenterol. 2007. PMID: 17426462
Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
Aceves SS, Bastian JF, Newbury RO, Dohil R. Aceves SS, et al. Among authors: dohil r. Am J Gastroenterol. 2007 Oct;102(10):2271-9; quiz 2280. doi: 10.1111/j.1572-0241.2007.01379.x. Epub 2007 Jun 20. Am J Gastroenterol. 2007. PMID: 17581266
Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids.
Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, Bastian JF, Broide DH. Aceves SS, et al. Among authors: dohil r. Allergy. 2010 Jan;65(1):109-16. doi: 10.1111/j.1398-9995.2009.02142.x. Epub 2009 Oct 1. Allergy. 2010. PMID: 19796194 Free PMC article.
A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation.
Aceves SS, Newbury RO, Dohil MA, Bastian JF, Dohil R. Aceves SS, et al. Among authors: dohil ma, dohil r. Ann Allergy Asthma Immunol. 2009 Nov;103(5):401-6. doi: 10.1016/S1081-1206(10)60359-6. Ann Allergy Asthma Immunol. 2009. PMID: 19927538
Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
Dohil R, Newbury R, Fox L, Bastian J, Aceves S. Dohil R, et al. Gastroenterology. 2010 Aug;139(2):418-29. doi: 10.1053/j.gastro.2010.05.001. Epub 2010 May 7. Gastroenterology. 2010. PMID: 20457157 Clinical Trial.
Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction.
Aceves SS, Chen D, Newbury RO, Dohil R, Bastian JF, Broide DH. Aceves SS, et al. Among authors: dohil r. J Allergy Clin Immunol. 2010 Dec;126(6):1198-204.e4. doi: 10.1016/j.jaci.2010.08.050. Epub 2010 Nov 3. J Allergy Clin Immunol. 2010. PMID: 21047675
Eosinophilic esophagitis: updated consensus recommendations for children and adults.
Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R, Falk GW, Gonsalves N, Gupta SK, Katzka DA, Lucendo AJ, Markowitz JE, Noel RJ, Odze RD, Putnam PE, Richter JE, Romero Y, Ruchelli E, Sampson HA, Schoepfer A, Shaheen NJ, Sicherer SH, Spechler S, Spergel JM, Straumann A, Wershil BK, Rothenberg ME, Aceves SS. Liacouras CA, et al. Among authors: dohil r. J Allergy Clin Immunol. 2011 Jul;128(1):3-20.e6; quiz 21-2. doi: 10.1016/j.jaci.2011.02.040. Epub 2011 Apr 7. J Allergy Clin Immunol. 2011. PMID: 21477849 Review.
Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.
Otani IM, Anilkumar AA, Newbury RO, Bhagat M, Beppu LY, Dohil R, Broide DH, Aceves SS. Otani IM, et al. Among authors: dohil r. J Allergy Clin Immunol. 2013 Jun;131(6):1576-82. doi: 10.1016/j.jaci.2013.02.042. Epub 2013 Apr 25. J Allergy Clin Immunol. 2013. PMID: 23623266 Free PMC article.
In responders epithelial mast cell numbers decreased from 62 to 19 per hpf (P < .001), were significantly lower than in nonresponders after therapy (P < .05), and correlated with eosinophil numbers (r = 0.75, P < .0001). ...

In responders epithelial mast cell numbers decreased from 62 to 19 per hpf (P < .001), were significantly lower than in nonresponders aft

64 results
Jump to page
Feedback